Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Vaccination is crucial for public health, but anti-vaccine movements are a concern.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Early immunosuppressive therapy leads to favorable outcomes in Filipino lupus patients with myocarditis.

Most patients with systemic lupus erythematosus in Malwa, India, show skin symptoms like photosensitivity and rashes.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Skin issues can indicate immune system problems.

Amphetamine use may not cause hair loss, "geezer" traits are normal aging, not all educated older people are stereotypes, and metronidazole can rarely cause lung disease.

Amphetamines may not directly cause hair loss.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Cosmetics and procedures can cause eye issues, from mild discomfort to serious conditions, due to allergies, toxins, or poor care.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.

Alopecia frontal fibrosante affects facial vellus hair and can be diagnosed with dermatoscopy.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Improving medical training is key to eradicating frambusia by 2030.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Nivolumab can cause hair loss as a rare side effect.

Chikungunya virus often causes skin issues and inflammation.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Nail changes from immunotherapy can be managed without stopping cancer treatment.